Biotech China 2014

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2010 Differential Regulation of Epidermal Function by VDR Coactivators. J Ster Biochem Mol Biol
2. 2010 Vitamin D and the Skin J Bone Min Metab
3. 2010 Vitamin D and Immune Function US Nephrology 4
4. 2010 Vitamin D: Newly Discovered Actions Require Reconsideration of Physiologic Requirements Trends in Endocrinology and Metabolism
5. 2010 Role of vitamin D in skin and Hair Vitamin D: New Research. Nova Science Publishers (in press)
6. 2010 Association of Prediagnostic Serum Vitamin D levels with the Development of Basal Cell Carcinoma J Invest Dermatol
7. 2009 Vitamin D and Immune Function: Understanding common pathways Current Osteoporosis Reports 7:58-63
8. 2009 Nonclassic actions of vitamin D J Clin Endocrinol Metab 94:26-34
9. 2009 Ultraviolet radiation, vitamin D, and epidermal carcinogenesis Expert Rev. Dermatol 4 :557-566
10. 2009 Vitamin D Regulation of Immune Function: Implications for Bone Loss during Inflammation Clinic Rev Bone Miner Metab 7:301-309
11. 2009 Quantification of the Vitamin D Receptor - Coregulator Interaction Biochemistry 48:1454-1461
12. 2009 Extra renal synthesis of 1,25-dihydroxyvitamin D and its health implications Vitamin D: Physiology, Molecular Biology, and Clinical Applications. Ed. M Holick, Human Press (in press)
13. 2009 Phosphatidylinositol 4-phosphate 5-kinase 1a mediates extracellular calcium induced keratinocyte differentiation Molec Biol Cell 20:1695-1704
14. 2009 Hypercalcemia and Overexpression of CYP27B1 in a Patient with Nephrogenic Systemic Fibrosis: Clinical Vignette and Literature Review J Bone Min Res 24:1135-1139
15. 2009 Vitamin D receptor and coactivators SRC 2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation J Invest Dermatol 129:1367-1378
16. 2009 Confessions of an extreme athlete San Francisco Medicine 82:35-36
17. 2009 Extra renal synthesis of 1,25 dihydroxyvitamin D and its Health Implications Clin Rev in Bone and Min Metab 7:114-125
18. 2008 Vitamin D, ultraviolet radiation, and skin cancer: a potential protective mechanism J Invest Dermatol 128:2357-2361
19. 2008 Integrins, IGF, and the skeletal response to load Osteoporosis International 19:1237-1246
20. 2008 The growth hormone/IGF-I/PTH axis in bone J Bone Min Res 23:581-583
21. 2008 Vitamin D and the immune system: role in protection against bacterial infection Current Opinion in Nephrology and Hypertension 17:348-352
22. 2008 Vitamin D deficiency/insufficiency in gastrointestinal diseases J Bone Min Res 22 (suppl 2):V50-54
23. 2008 Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25 dihydroxyvitamin D3 J invest Dermatol 128:816-824
24. 2008 Inactivation of the calcium sensing receptor inhibits E-cadherin-mediated cell-cell adhesion and calcium-induced differentiation in human epidermal keratinocytes. J Biol Chem 283:3519-3528
25. 2008 The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development Science Signaling 1:1-13
26. 2008 Vitamin D: Production, metabolism, mechanism of action, and clinical requirements Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 7th edition. Ed. C Rosen. Pp 141-149
27. 2007 Insulin-like Growth Factor-I Stimulates Recovery of Bone Lost after a Period of Skeletal Unloading J Appl Physiol 103:125-131
28. 2007 Constitutive activity of the osteoblast Ca2+-sensing receptor promotes loss of cancellous bone Endocrinology 148:3156-3163
29. 2007 The IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J Bone Min Res 22:1329-1337
30. 2007 Agents that affect bone mineral homeostasis Katzung BG (ed) Basic and Clinical Pharmacology, 9th edition, Lange, Los Altos, Calif. Pp 706-723, revised 2009
31. 2007 Metabolic Bone Disease Basic and Clinical Endocrinology. Ed. DG Gardner and DS Shoback. Lange Medical Books/McGraw-Hill, New York pp 281-345, revised 2009
32. 2007 Integrin Regulation of the IGF-I Receptor in Bone, and the Response to Load Clinical Reviews in Bone and Mineral Metabolism 5:222-233
33. 2007 What is new in vitamin D: 2006-2007? Current Opinion in Rheumatology 19:383-388
34. 2007 Evaluation of Fetal Bone Structure and Mineralization in IGF-I Deficient Mice Using Synchrotron Radiation Micro-tomography andFourier Transform Infrared Spectroscopy Bone 40:160-168
35. 2007 Insulin-Like Growth Factor-I Is Essential For Embryonic Bone Development Endocrinology 147:4753-4761
36. 2007 Sequential regulation of keratinocyte differentiation by 1,25(OH)2D3, VDR, and its coactivators. J Ster Biochem Molec Biol 103:396-404
37. 2007 Regulation of human epidermal keratinocyte differentiation by the vitamin D receptor and its coactivators DRIP205, SRC2, and SRC3 J Invest Dermatol 127:874-880
38. 2007 The role of the calcium sensing receptor in regulating intracellular calcium handling in human epidermal keratinocytes J Invest Dermatol 127:1074-1083
39. 2007 Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D dependent mechanism J Clin Invest 117:803-811
40. 2007 Differential role of two VDR coactivators, DRIP205 and SRC-3, in keratinocyte proliferation and differentiation J Ster Biochem Mol Biol 103:776-780
41. 2007 The recruitment of phosphatidylinositol 3-kinase to the E-cadherin/catenin complex at the plasma membrane is required for calcium-induced phospholipase C-g 1 activation and human keratinocyte differentiation J Biol Chem 282:8695-8703
42. 2007 Diffuse osteopenia and vitamin D deficiency: Case study Endocrine News October, p 22
43. 2006 The Role of IGF-I Signaling in Regulating Osteoclastogenesis. J Bone Min Res 21:1350-1358
44. 2006 Hairless suppresses vitamin D receptor transactivation in human keratinocytes Endocrinology 147:314-323
45. 2006 Development and progression of alopecia in the vitamin D receptor null mouse J Cell Physiol 207:340-353
46. 2006 Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I. J Endocrinol 189: 279-287
47. 2006 For whom the bugs toll; They toll for D. Commentary on Liu et al Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Science 311:1770-3, 2006 in BondKEy-Osteovision 3:12-15
48. 2005 Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase dependent activation of phospholipase C-g1. Molec Biol Cell 16: 3236-3246
49. 2005 Vitamin D: Role in Skin and Hair Vitamin D, 2nd Edition. Ed. by: D Feldman, FH Glorieux, JW Pike. Elsevier, lnc. pp.609-630, revised 2008
50. 2005 Vitamin D and Skin Cancer: A Problem in Gene Regulation J Steroid Biochem Molec Biol 97:83-91
51. 2005 Vitamin D and the Epidermis Skin Barrier, Ed. By PM Elias and KR Feingold. Marcel Dekker, Inc. (in press)
52. 2005 Expression and functional assessment of an alternatively spliced extracellular Ca2+-sensing receptor in growth plate chondrocytes. Endocrinology 146:5294-5303
53. 2005 Phospholipase Cg1 is required for activation of store-operated channels in human keratinocytes J Invest Dermatol 124:187-197
54. 2005 Impact of Skeletal Unloading on Bone Formation: New Understanding of Molecular Mechanisms J Ortho Sci
55. 2004 Vitamin D. Meeting report from the 26th Annual Meeting of the American Society fro Bone and Mineral Research BoneKEy-Osteovision 1:19-23
56. 2004 PTH differentially regulates expression of RANKL and OPG. J Bone Min Res 19:235-244
57. 2004 Skeletal unloading induces resistance to IGF-I by inhibiting activation of the IGF-I signaling pathways J Bone Min Res 19:436-446
58. 2004 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis J Invest Dermatol 122:984-992
59. 2004 The role of calcium-sensing receptor in epidermal differentiation. Cell Calcium 35:265-273
60. 2004 Vitamin D regulated keratinocyte differentiation J Cell Biochem 92:436-444
61. 2004 Mice lacking 25OHD 1a-hydroxylase demonstrate decreased epidermal differentiation and barrier function J Steroid Biochem Molec Biol 89-90:347-353
62. 2004 Calcium and 1,25(OH)2D3: interacting drivers of epidermal differentiation J Steroid Biochem Molec Biol 89-90:355-360
63. 2004 Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in VDR transactivation during keratinocyte differentiation J Steroid Biochem Molec Biol 89-90:273-276
64. 2004 Vitamin D and skin cancer J Nutrn 134:3472S-3478S
65. 2004 Metabolic Bone Disease Basic and Clinical Endocrinology. Ed. FS Greenspan and DG Gardner. Lange Medical Books/McGraw-Hill, New York pp 295-36, revised in 2007, 2010
66. 2003 Two distinct coactivators, DRIP/Mediator and SRC/p160, are differentially involved in vitamin D receptor transactivation during keratinocyte differentiation Molec Endocrinol 17:2329-2339
67. 2003 Vitamin D regulated keratinocyte differentiation: role of coactivators.  J Cell Biochem 88:290-295
68. 2003 Biochemical regulation of breast cancer cell expression of S1P2 (EDG-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate. J Cell Biochem 88:732-743
69. 2003 Chapter 11. The role of the calcium receptor in calcium regulated keratinocyte differentiation The Calcium Sensing Receptor. Ed by EM Brown and N Chattopadhyay. Kluwer Academic Publishers pp 245-265
70. 2003 Squamous Cell Carcinomas fail to respond to the prodifferentiating actions of 1,25(OH)2D: Why? Recent Results in Cancer Research 164: 110-122. Ed. J Reichrath, M Friedrich, W Schmidt, and W Tilgen. Springer-Verlag publishers
71. 2003 Human keratinocyte ATP2C1 localizes to the Golgi and controls Golgi Ca2+ stores J Invest Dermatol 121:688-94
72. 2003 The Impact of Skeletal Unloading on Bone Formation Grav Space Biol Bull 16:45-54
73. 2003 bFGF administration lowers the phosphate threshold for mineralization in bone marrow stromal cells Calc Tiss Internl 73:147-152
74. 2003 Role of protein kinase Ca in calcium induced keratinocyte differentiation: defective regulation in squamous cell carcinoma J Cell Physiol 195:249-259
75. 2003 Skeletal unloading induces resistance to insulin-like growth factor-I on bone formation Bone 32:669-680
76. 2002 The mechanism of 1,25 dihydroxyvitamin D3 auto-regulation in keratinocytes J Biol Chem 277:36987-36990
77. 2002 Vitamin D: Production, Metabolism, and Mechanisms of Action Endotext.Org. Ed. by LJ DeGroot, MDTEXT.Com, revised every 2-3 years since
78. 2002 Calcium and vitamin D regulated keratinocyte differentiation. Modern Trends in Skin Pharmacology: Molecular and Clinical Aspects. Ed. D Tsambaos, H Merk. Parissianos Medical Publishers.pp 27-45
79. 2002 The vitamin D response element of the involucrin gene mediates its regulation by 1,25 dihydroxyvitamin D. J Invest Dermatol 119:1109-1113
80. 2002 Mechanical and chemical characteristics of mineral produced by bFGF-treated bone marrow stromal cells in vitro Tiss Engineer 8:931-939.
81. 2002 Insulin like growth factor-I is required for the anabolic actions of parathyroid hormone on mouse bone J Bone Min Res 17:1570-1578
82. 2002 The epidermal expression of the full-length extracellular calcium-sensing receptor is required for normal keratinocyte differentiation. J Cell Physiol 192:45-54
83. 2002 Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth J Invest Dermatol 118:11-16
84. 2001 Calcium and vitamin D regulated keratinocyte differentiation. Molec Cell Endocrinol 177:161-171
85. 2001 Selective inhibition of vitamin D hydroxylases in human keratinocytes. Steroids 66: 409-422
86. 2001 Osteoblasts in culture respond to pulsatile fluid flow with short-term increases in PGE2 production but no change in cell proliferation or mineralization J Appl Physiol 90:1849-1854.
87. 2001 The skeletal structure of insulin-like growth factor-I deficient mice J Bone Min Res 16:2320-2329.
88. 2001 The extracellular calcium-sensing receptor is required for calcium-induced differentiation in human keratinocytes J Biol Chem 276:41079-41085
89. 2001 The role of phospholipase C-g1 in 1,25(OH)2D regulated keratinocyte differentiation. Steroids 66: 339-345
90. 2001 The plight of the physician-scientist in the American Society for Bone and Mineral Research: The problems and recommendations for improvement. ASBMR News. J Bone Min Res 16: I-II
91. 2001 Inhibition of 1,25-dihydroxyvitamin D-induced keratinocyte differentiation by blocking the expression of phospholipase C-g1 J Invest Dermatol 117:1250-1254
92. 2000 Requirement of vitamin D receptor in epidermal differentiation and hair follicle recycling Vitamin D endocrine system: Structural, biological, genetic, and clinical aspects. Ed. AW Norman, R Bouillon, M Thomasset. University of California, Riverside publishers pp 623-626
93. 2000 Stimulation of PPAR alpha promotes epidermal keratinocyte differentiation in vivo J Invest Dermatol 115:353-360
94. 2000 Oxysterols induce differentiation in human keratinocytes and increase AP-1-dependent involucrin transcription J Invest Dermatol 114:545-553
95. 2000 Requirement of an AP-1site in the calcium response region of the involucrin promoter J Biol Chem 275:24080-24088
96. 2000 Farnesol stimulates differentiation in epidermal keratinocytes via PPARa. J Biol Chem 275: 11484-11491
97. 2000 The calcium sensing receptor and its alternatively spliced form in murine epidermal differentiation J Biol Chem 275:1183-1190
98. 2000 The role of phospholipase C-g1 in 1a,25-dihydroxyvitamin D regulated keratinocyte differentiation Vitamin D endocrine system: Structural, biological, genetic, and clinical aspects. Ed. AW Norman, R Bouillon, M Thomasset. University of California, Riverside publishers pp 597-604.
99. 2000 Effect of Vitamin D on keratinocyte proliferation and differentiation Vitamin D in Dermatology. Ed by K Kragballe. Marcel Dekker, lNY pp 75-109
100. 1999 Differences in calcium metabolism between black and white men and women Mineral and Electrolyte Metabolism 25:178-184
101. 1999 Age related changes in mineral metabolism Osteoporosis in men. Ed by Eric Orwoll. Acad press, NY pp179-195.
102. 1999 Effects of calcium receptor activator on the cellular response to calcium in human keratinocytes J. Invest Dermatol 113:340-345
103. 1999 Phospholipase C- g1 is required for calcium induced keratinocyte differentation J Biol Chem 274:20421-20424
104. 1999 The response of bone to unloading J. Bone Min Metab 17:233-244
105. 1999 Six putative IQ motifs of the chicken intestinal brush border myosin I are involved in calmodulin binding Arch Biochem Biophys 361:94-100
106. 1999 Drugs for altering calcium homeostasis: treatment of osteoporosis Quick Look Pharmacology. Fence Creek Publishing, Inc. Madison, CT Ed. by RB Raffa. pp 156-157
107. 1999 Bone and mineral changes induced by skeletal unloading in the mature male rat. Amer J Physiol 276:E62-E69
108. 1999 Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone an to insulin-like growth factor-I J Bone Min Res 14:21-31
109. 1999 1,25 Dihydroxyvitamin D3 enhances the calcium response of keratinocytes J Cellular Physiol 178:188-196
110. 1998 Differential regulation of vitamin D-responsive elements in normal and transformed keratinocytes. J Invest Derm 110:730-733
111. 1998 Importance of gravity in the maintenance of bone density Proceedings of the Second Shizuoka Forum on Health and Longevity; pp 298-306
112. 1998 All-trans retinoic acid blocks the antiproliferative prodifferentiating actions of 1,25 dihydroxyvitamin D3 in normal keratinocytes J Cell Physiol 174:1-8
113. 1998 differentiation is stimulated by activators of the nuclear hormone receptor PPAR J Invest Dermatol 110:368-375
114. 1998 The calcium sensing receptor and its alternatively spliced form in keratinocyte differentiation J Biol Chem 273:23344-23352
115. 1997 Decrease of Ca2+-ATPase activity in human keratinocytes during calcium induced differentiation J Cell Physiol 172:146-154
116. 1997 Racial differences in bone density between young adult black and white subjects persist after adjustment for anthropometric, lifestyle, and biochemical changes J Clin Endocrinol Metab 82: 429-434
117. 1997 The expression of the gap junctional protein Cx43 is restricted to proliferating and non-differentiated normal and transformed keratinocytes Exp Dermatol 6:167-174
118. 1997 Cloning of the human 25-hydroxyvitamin D 1 -hydroxylase and mutations causing vitamin D-dependant rickets type 1 Molecular Endocrinology 11:1961-1970
119. 1997 Skeletal unloading inhibits the in vitro proliferation and differentiation of rat osteoprogenitor cells Amer J Physiol 273:E1133- E1139.
120. 1997 Vitamin D: a calciotropic hormone regulating calcium-induced keratinocyte differentiation J Am Acad Dermatol 37:S42-S52
121. 1997 Biochemical markers in the assessment of bone disease Am J Med 103:427-436.
122. 1997 Space flight and the skeleton: lessons for the earthbound Endocrinologist 7: 10-22
123. 1997 Spaceflight and the skeleton Gravitational and Space Biol Bull 10:119-135
124. 1997 Molecular mechanisms underlying 1,25(OH)2 D regulation of epidermal differentiation : Vitamin D Chemistry, Biology and Clinical Applications of the Steroid Hormone. Ed. by: Anthony W. Norman, Roger Bouillon, and Monique Thomasset
125. 1997 Synergistic induction by 1,25-Dihyroxyvitamin D3 and all-trans retinoic acid of the human phospholipase C- 1 gene Vitamin D Chemistry, Biology and Clinical Applications of the Steroid Hormone. Ed. by: Anthony W. Norman, Roger Bouillon, and Monique Thomasset.
126. 1997 Cloning of the human phospholipase C- 1 promoter and identification of a DR6-type vitamin D-responsive element J Biol Chem 272: 6573-6577
127. 1997 Regional responsiveness of the tibia to intermittent administration of parathyroid hormone as affected by skeletal unloading J Bone Miner Res 12:1068-1074
128. 1996 Regulation of involucrin gene expression by calcium in normal human keratinocytes. Frontiers in Bioscience 1: 16-24
129. 1996 Drug Induced Osteomalacia Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 3rd edition. Ed by: MJ Favus. Lippincott-Raven pp. 333-337
130. 1996 Osteoporosis in Gastrointestinal, Pancreatic, and Hepatic Diseases Osteoporosis. Ed by: R Marcus, D Feldman, J Kelsey. Academic Press, NY. pp. 863-884
131. 1996 Evidence for separate control mechanisms at the message, protein, and enzyme activation levels for transglutaminase during calcium-induced differentiation of normal and transformed human keratinocytes J Invest Dermatol 106: 154-161
132. 1996 1,25(OH)2D3 modulated calcium induced differentiation J Invest Dermatol Symposium Proceedings 1: 22-27
133. 1996 Squamous carcinoma cell lines fail to respond to 1,25 dihydroxyvitamin D despite normal levels of the vitamin D Receptor J Invest Dermatol 106: 522-525
134. 1996 Changes in calcium responsiveness and handling during keratinocyte differentiation: potential role of the calcium receptor J Clin Invest 97: 1085-1093
135. 1996 Zipper protein, a B-G protein with the ability to regulate actin/myosin 1 interaction in the intestinal brush border J Biol Chem 271:9075-9083
136. 1996 Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogs in breast cancer cells. Cancer Research 56: 2789-2794
137. 1995 Vitamin D: new actions, new analogs, new therapeutic potential: update 1995 Hormonal Regulation of Bone Mineral Metabolism ed by DD Bikle and A Negro-Villar,Endocrine Society Press, Bethesda pp 77-83
138. 1995 Vitamin D: a bright future for the sunshine hormone Scientific American Science and Medicine (March/April): 58-67.
139. 1995 Hormonal Regulation of Bone Mineral Metabolism Endocrine Society Press, Bethesda, MD
140. 1995 22-oxacalcitriol is a less potent regulator of keratinocyte proliferation and differentiation due to decreased cellular uptake and enhanced catabolism. J Invest Dermatol 105: 693-698
141. 1995 Skeletal unloading induces selective resistance to the anabolic actions of growth hormone on bone J Bone Miner Res 10: 1168-1176
142. 1995 Serum levels of free 1,25 dihydroxyvitamin D in vitamin D toxicity Ann Int Med 122: 511-513.
143. 1995 1,25 dihydroxyvitamin D upregulates the phosphotidyl inositol signalling pathway in human keratinocyte by increasing phospholipase C levels J Clin Invest 96: 602-609
144. 1995 The molecular response of bone to growth hormone during skeletal unloading: regional differences Endocrinology 136: 2099-2109
145. 1995 1,25(OH)2D3 regulated human keratinocyte proliferation and differentiation: basic studies and their clinical application J Nutr 125: S1709-S1714.
146. 1994 Production of 1,25 dihydroxyvitamin D3 by perfused pig skin. J Invest Dermatol 102: 796-798
147. 1994 1,25 dihydroxyvitamin D potentiates the keratinocyte response to calcium. J Biol Chem 269:14723-14729
148. 1994 Impact of skeletal unloading on bone formation: role of systemic and local factors Acta Astron 33:119-129
149. 1994 Role of vitamin D, its metabolites, and analogs in the management of osteoporosis Rheum Dis Clin NA 20:759-775.
150. 1994 1,25(OH)2D modulated calcium induced keratinocyte differentiation: from the culture dish to the psoriatic patient In Vitamin D, a pluripotent steroid hormone:structural studies,molecular endocrinology,and clinical applications.ed by AW Norman, R Bouillon, M Thomasset,pref Walter de Gruyter,Berlin (New York),pp 568-575
151. 1994 Altered skeletal pattern of gene expression in response to space flight: comparison to the response to hindlimb elevation Amer J Physiol 267: E822-E827
152. 1994 Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage J Bone Miner Res 9: 1777-1787
153. 1994 Skeletal unloading induces resistance to insulin like growth factor 1. J Bone Miner Res 9: 1789-1796
154. 1994 Expression of the genes for the insulin like growth factors and their receptors in bone during skeletal growth Amer J Physiol 267: E278-E286
155. 1994 Regulation of calmodulin binding to the ATP extractable 110 kd protein (myosin 1) from chicken duodenal brush border by 1,25(OH)2D3. Biochim Biophys Acta 1190: 329-336
156. 1993 Formulary of drugs commonly used in treatment of mineral disorders Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Ed by MJ Favus. Raven Press, NY
157. 1993 Alcohol induced bone disease Osteoporosis: Nutritional Aspects ed by AP Simopoulos and C Galli. Karger Press, Basel pp 53-79.
158. 1993 Hyper and Hypoparathyroidism Conn's Current Therapy. Rakel RE (eds). WB Sanders Co, pp 620-623
159. 1993 Vitamin D, calcium, and epidermal differentiation Endocrine Reviews 14:3-19
160. 1993 Regulation of keratinocyte growth, differentiation, and vitamin D metabolism by analogs of 1,25 dihydroxyvitamin D J Invest Derm 101: 713-718
161. 1993 Skeletal unloading decreases the production of 1,25 dihydroxyvitamin D. Amer J Physiol 264: E712-716
162. 1993 Alcohol induced bone disease: relationship to age and parathyroid hormone levels. Alcoholism: Clinical and Experimental Research 17: 690-695.
163. 1993 Metabolic acidosis reverses the increase in serum 1,25(OH)2D in phosphorus restricted normal men Am J Physiol 263: E1164-1169.
164. 1993 Zipper protein: a newly described tropomyosin like protein of the intestinal brush border J Biol Chem 268:620-626
165. 1993 Localization and quantitation of calcium pools and calcium binding sites in cultured human keratinocytes. J Cellular Physiol 154: 101-112
166. 1993 Elevated 1,25 dihydroxyvitamin D levels in patients with chronic obstructive pulmonary disease treated with prednisone J Clin Endocrinol Metab. 76:456-461
167. 1993 Regulation of bone mineral homeostasis: an integrated view Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Ed by MJ Favus. Raven Press, NY, pp 76-80
168. 1992 Progestin antagonism of estrogen stimulated 1,25 dihydroxyvitamin D levels. J Clin Endo Metab 75:519-523.
169. 1992 ATP stimulated phosphoinositide metabolism mobilizes intracellular calcium and inhibits terminal differentiation of human epidermal keratinocytes J Clin Invest 90:42-51.
170. 1992 Lanthanum influx into cultured human keratinocytes: effect on calcium flux and terminal differentiation. J Cell Physiol 151:623-629
171. 1992 What can we learn about the impact of space flight on bone metabolism? Proceedings of the conference " Space Flight and Bone Metabolism." Tokyo, Japan
172. 1992 Clinical Counterpoint - Vitamin D: new actions, new analogs, new therapeutic potential Endocrine Reviews 13: 765-784.
173. 1992 The effects of dietary protein deficiency on mineral metabolism and bone mineral density. Am J Clin Nutr 56:314-319
174. 1992 Bone disease due to nutritional, gastrointestinal, and hepatic disorders Coe FL, Favus MJ (eds). Disorders of bone and mineral metabolism. Raven Press, NY, pp 951-976.
175. 1991 Squamous carcinoma cell lines produce 1,25-dihydroxy­vitamin D but fail to respond to its prodifferentiating effect J Invest Dermatol 97:435-441
176. 1991 Cloning and sequencing a vitamin D inducible protein from the intestine with an extensive leucine zipper motif and homology to tropomyo­sin/myosin. Vitamin D: Gene regulation, structure-function analysis and clinical application. ed: Norman AW, Bouillon R, Thomasset M. Walter de Gruyter, Berlin, 1991. PP 689-90.
177. 1991 Uncoupling of the calcium sensing mechanism and differentiation in squamous carcinoma cell lines Exper Cell Res 192:567-573
178. 1991 The role of intracellular free calcium in the cornified envelope formation of keratinocytes: differences in the mode of action of extracellular calcium and 1,25-dihydroxyvit­amin D. J Cell Physiol 146:94-100
179. 1991 Tumor necrosis factor-alpha regulation of 1,25-dihydroxyvitamn D production by human keratinocytes Endocrinology 129:33-38.
180. 1991 Regulation of calmodulin binding to the ATP extractable 110k D protein from chicken duodenal brush border Vitamin D: Gene regulation, structure-function analysis and clinical application. Ed: AW Norman, R Bouillon, M Thomasset. Walter de Gruyter, Berlin, 1991 pp 691-92
181. 1991 Epidermal vitamin D metabolism, function and regulation Adv In Lipid Research 24:321-341
182. 1991 Effects of 17 -estradiol and medroxyproge­sterone on the serum concentration of 1,25-dihydroxyvitamin D in perimenopausal women Vitamin D: Gene regulation, structure-function analysis and clinical application. ed: AW Norman, R Bouillon, M Thomasset. Walter de Gruyter, Berlin, 1991 pp 845-46
183. 1991 Alcohol induced bone disease in osteoporosis 1990. ed by C Christiansen and K Overgaard; Handelstrykkeriet Aalborg, Denmark; pp 1544-51.
184. 1991 Limited tissue distribution of the intestinal brush border myosin I protein. Gastro­enterology 100:395-402.
185. 1990 Metabolism and functions of vitamins A, D, and K Zakin D, Boyer TD (eds) Hepatology, 2nd ed Saunders, Philadelphia pp 182-196
186. 1990 Calcium regulation of growth and dif­ferentiation of normal human keratinocytes: modulation of differentiation competence by stages of growth and extra­cellular calcium. J Cell Physiol 143:294-302
187. 1990 Different responses to trabecular and cortical bone to 1,25(OH)2D3 infusion. Am J Physiol 259:E715-22
188. 1990 Regulation of intestinal calcium transport by vitamin D [1,25(OH)2D]: role of membrane structure In: Aloia RC, Curtain CC, Gordon LM, (eds) Membrane Transport and Information Storage. Wiley-Liss, New York, pp 191-219
189. 1989 Agents that affect bone mineral homeostasis Katzung BG (ed) Basic and Clinical Pharmacology, 4th edition 1989 through 9th edition, 2004, Lange, Los Altos, Calif
190. 1989 Free and not total 1,25-dihydroxyvitamin D regulates 25 hydroxyvitamin D metabolism by keratinocytes Endocrinology 124:649-654
191. 1989 Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma Endocrinology 124:655-660
192. 1989 Calmodulin binding to the intestinal brush border membrane: comparison to other calcium-binding proteins Biochim Biophys Acta 1010:122-127
193. 1989 Isotope labelling affects 1,25 di­hydroxyvitamin D metabolism Biochemistry 28:1278-1281
194. 1989 Binding and biological effects of tumor necrosis factor-alpha on cultured human neonatal foreskin keratinocytes J Clin Invest 83:816-821
195. 1989 Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis J Clin Invest 83:1527-32
196. 1989 Bone res­ponse to normal weightbearing after a period of skeletal unloading Am J Physiol 257:E606-610
197. 1989 Serum vitamin D metabolites are not responsible for low turnover os­teoporosis in chronic liver disease J Clin Endo Metab 69:1234-1239
198. 1989 Effect of simulated weightlessness on rat osteocalcin and bone calcium. Amer J Physiol 257:R1103-9, 1989.
199. 1988 Use of HPLC and On‑line Radioactivity Monitoring in Studies o f Vitamin D Metabolism. Reich A, Lucus-Reich S, Parvez S. (ed) Progress in HPLC, vol 4. Utrecht, International Science pp 93-127
200. 1988 Vitamin D and epidermal differentiation: evidence for a role of endogenously produced vitamin D metabolites in keratin­ocyte differentia­tion Skin Pharmacol 1:149-160
201. 1988 Glucocorticoids and the inhib­ition of bone formation induced by skeletal unloading Am J Physiol, 255:E875-E879
202. 1988 Serum dihydrotachysterol levels and biologic action in normal man. J Clin Endo Metab 67:198-202
203. 1988 Measurement of free vitamin D metabolite levels: biological and clinical significance. Norman AW, Schaefer K, Grigoleit HG, Herrath DV (eds) Vitamin D: Molecular,Cellular,and Clinical Endocrinology. Walter de Gruyter,New York, pp 703-9.
204. 1988 Vitamin D metabolite production and function in keratinocytes Ann NY Acad Sci 548:27-44
205. 1988 The effects of alcohol abuse on bone Comprehensive Therapy 14:16‑20
206. 1988 Accentuated transpleu­ral gradient of "total" and "free" 1,25-dihyroxyvitamin D in patients with tuberculous pleuritis Norman AW, Schaefer K, Grigoleit HG, Herrath DV (eds) Vitamin D: Molecular, Cellular and Clinical Endocrinology. Walter de Gruyter, New York pp 857-8
207. 1988 The 105 kD calmodulin binding protein from intestin­al brush border membrane (BBM) is a calcium transport protein Norman AW, Schaefer K, Grigoleit HG, Herrath DV (eds) Vitamin D: Molecular, Cellular, and Clinical Endocrinol­o­gy. Walter de Gruyter, New York pp 577-8
208. 1988 Biochemical and morphological characteriza­tion of growth and differentiation of normal human neonatal keratino­cytes in a serum free medium. J Cell Physiol 134:229-239.
209. 1988 1,25‑dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation J Biol Chem 263:5390-5395
210. 1987 The effects of simulated weightlessness on bone maturation. Endocrinology 120:678‑84
211. 1987 Effect of dietary acid and calcium on 25‑hydroxyvitamin D metabolism by chick kidney J Bone Min Res 2:289‑96.
212. 1987 The effect of vitamin D status on cutaneous sterologenesis in vivo and in vitro Biochim Biophys Acta 930:193‑200
213. 1986 Stimulation by 1,25‑dihydroxyvitamin D3 of adenylate cyclase along the villus of chick duodenum Endocrinology 119:2568‑73.
214. 1986 Assessment of free fractions of 25‑hydroxyvitamin D in serum and its regulation by albumin and the vitamin D‑binding protein. J Clin Endocrinol Metab 63:954‑9.
215. 1986 Free 25‑hydroxy­vitamin D levels are normal in subjects with liver disease and reduced total 25‑hydroxy­­vitamin D levels J Clin Invest 78:748‑52.
216. 1986 Chronic 1,25‑dihydroxyvitamin D3 administration in the rat reduces the serum concentra­tion of 25‑hydroxyvitamin D by increasing metabolic clearance rate J Clin Invest 78:622‑8
217. 1986 1,25‑dihydroxyvitamin D3 production by human keratinocytes: kinetics and regulation. J Clin Invest 78:557-566
218. 1986 The effect of ethanol on intestinal calcium transport in chicks. Gastroenterology 91:870‑6.
219. 1986 The role of 1,25‑dihydroxyvitamin D in the inhibition of bone formation in­duced by skeletal unloading Endocrinology 118:948‑54
220. 1986 Skeletal response to dietary calcium in a rat model simulating weightlessness. J Bone Min Res 1:191‑7.
221. 1986 Neonatal human foreskin keratinocytes produce 1,25‑dihydroxyvitamin D3 Biochemistry 25:1545‑8
222. 1986 The villus gradient of brush border membrane calmodu­lin and the calcium‑independent calmodulin‑binding protein paral­lels that of calcium­ accumulating activity Endocrinology 118:727‑32.
223. 1986 The temporal response of bone to unloading Endocrinology 118:733‑42
224. 1986 Hyperparathyroidism and hypoparathyroidism Rakel RE (ed) Conn's Current Therapy. Saunders, Philadelphia, pp 504‑7
225. 1986 Chronic administration of 1,25‑dihydroxyvitamin D3: increased bone but impaired minerali­zation Endocrinology 119:2580‑5
226. 1985 Osteomalacia and rickets Wyngaarden JB, Smith LH Jr, Plum F (eds) Cecil Textbook of Medicine, 17th ed 1985 pp 1425‑31, 18th ed 1988 pp 1479-85, 19th ed 1991, pp 1406-1412, Saunders, Philadelphia
227. 1985 Bone loss during simulated weightless­ness: is it glucocorticoid‑mediated? Physiologist 28:S125‑4
228. 1985 1,25‑dihydroxyvitamin D increases the in­tracellular free calcium concentration of duodenal epithelial cells Norman AW, Schaefer K, Grigoleit HG, Herrath DV (eds) Vitamin D: Chemical, Biochemical and Clinical Update. Walter de Gruyter, New York, p 416
229. 1985 Mechanisms by which 1,25‑dihydroxyvitamin D regulates calmodulin binding to the duodenal brush border membrane Norman AW, Schaefer K, Grigoleit HG, Herrath DV (eds) Vitamin D: Chemical, Biochemical and Clinical Update. Walter de Gruyter, New York, pp 393‑5.
230. 1985 Vitamin D Wyngaarden JB, Smith LH Jr, Plum F (eds) Cecil Textbook of Medicine, 17th ed 1985 pp 1423-5, 18th ed 1988 pp 1477-9, 19th ed 1991 pp 1404-1406, Saunders, Philadelphia
231. 1985 1,25‑dihydroxyvitamin D increases calmodulin binding to specific proteins in the chick duodenal brush border membrane J Clin Invest 76:2312‑6.
232. 1985 Serum protein binding of 1,25‑dihydroxyvi­tamin D: a reevaluation by direct measurement of free metabolite levels J Clin Endocrinol Metab 61:969‑75
233. 1985 Bone disease in alcohol abuse. Ann Intern Med 103:42‑8
234. 1984 Calmodulin as a mediator of 1,25(OH)2D regulated intestinal calcium transport. Cohn DV, Fujita T, Potts JT Jr, Talmage RV (eds) Endocrine Control of Bone and Calcium Metabolism. Excerpta Medica, Amsterdam, pp 320‑3
235. 1984 Separation of isotopically labeled vita­min D metabolites by high‑performance liquid chromatography J Chromatogr 303:229‑33
236. 1984 Measurement of 25,26‑dihydroxyvitamin D: the importance of the configuration of the C‑25 hydroxyl group Biochemistry 23:6920‑5.
237. 1984 The relationship of membrane fluidity to calcium flux in chick intestinal brush border membranes Endocrinology 114:260‑7
238. 1984 Effects of simulated weightlessness on bone mineral metabolism Endocrinology 114:2264‑70
239. 1984 Calmodulin may mediate 1,25‑dihydroxy vitamin D‑stimulated intestinal calcium transport FEBS Lett 174:30‑3
240. 1984 Acute but not chronic metabolic acidosis disturbs 25 hydroxyvitamin D metabolism. Kidney Int 25:47‑52
241. 1984 Differential response of duodenal epithelial cells to 1,25‑dihydroxyvitamin D3 according to position on the villus: a comparison of calcium uptake, calcium binding protein, and alkaline phosphatase activity Endocrinology 115:2077‑84
242. 1984 The role of calmodulin in 1,25‑dihy­droxy­vitamin D regulation of calcium transport across the intestinal brush bor­der membrane Bronner F, Peterlik M (eds) Epithelial Calcium and Phosphate Transport: Molecular and Cellular Aspects. Liss, New York, pp 193‑8
243. 1984 Free 1,25‑dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver dis­ease J Clin Invest 74:1966‑74.
244. 1983 Calcium flux across chick duodenal brush border membrane vesicles: regulation by 1,25‑dihydroxyvitamin D Endocrinology 113:2072‑80
245. 1983 Simulating certain aspects of hypogravity: effects on bone maturation in the nonweight bearing skeleton Aviation Space Environ Med 54:1080‑4
246. 1983 Calcium potentiates the cyclic nucleotide and phospha­turic response to parathyroid hormone infusion J Clin Endocrinol Metab 56:11‑7
247. 1983 The adaptive response of humans to changes in dietary calcium: relationship between vitamin D regulated intestinal function and serum 1,25‑dihydroxy vitamin D levels Gstroenterology 84:314‑23
248. 1983 Assay of Calcium‑regulating Hormones Springer‑Verlag, New York
249. 1983 Calcium absorption and vitamin D metabolism Clinics in Gastroen­terology 12:379‑93
250. 1983 Fluoride treatment of osteoporosis: a new look at an old drug (editorial). Ann Intern Med 98:1013‑5
251. 1982 Calcium transport from the intestine and in­to bone in a rat model simulating weightlessness Physiologist 25:S143‑4
252. 1982 The vitamin D endocrine system Stollerman GH (ed) Advances in Internal Medicine. Year Book Medical Publishers, pp. 45‑71
253. 1982 Calcium transport by chick duodenal brush border membrane vesi­cles Norman AW, Schaefer K, Herrath DV, Grigoleit HG (eds) Vitamin D: Chemical, Biochemical, and Clinical Endocrinology of Calcium Metabolism. de Gruyter, New York, pp 313‑5
254. 1982 Pharmaco­kinetics and pharmacodynamics of 1,25‑dihydroxyvitamin D in the chick Endocrin­ology 111:939‑46
255. 1981 The intestinal response to vitamin D. Reviews of Physiol, Biochem, Pharmacol 89:63‑143
256. 1981 In vitro stimulation of 25‑hydroxy­chole­cal­ciferol 1 ‑hydroxy­lation by parathyroid hormone in chick kidney slices: evi­dence for a role of 3'5'‑cyclic AMP Endocrinology 108:1002‑6
257. 1981 Action of vitamin D on the intes­tinal calcium transport Ann NY Acad Sci 372:481‑501
258. 1980 Studies of chick renal mitochondrial 25 hydroxyvitamin D3 24‑hy­droxylase Biochim Biophys Acta 615:208‑22.
259. 1980 Vitamin D: the sunshine hormone Present Concepts in Internal Medi­cine 13:94‑108
260. 1980 The effects of 1 ‑hydroxyvitamin D3 on the rachitic chick intestine: a comparison to the effect of 1,25‑dihydroxyvitamin D3 Calcif Tissue Int 32:9‑17
261. 1980 Calcium accumu­la­tion by chick intestinal mitochondria: regulation by vitamin D3 and 1,25‑dihydroxy vitamin D3 Biochim Biophys Acta 598:561‑74.
262. 1980 Influence of cyclo­heximide and 1,25‑dihydroxyvitamin D3 on mitochondrial and vesicle minera­liza­tion in the intestine Cell Calcium 1:69‑79
263. 1980 Prolactin but not growth hormone stimulates 1,25‑dihydroxyvitamin D3 production by chick renal preparations in vitro Endocrinology 107:81‑4.
264. 1979 Is 1,24,25(OH)3D the princi­pal intestinal metabolite in vitamin D repleted chicks? Norman AW, Schaefer K, Herrath DV, Grigoleit HG, Coburn JW, DeLuca HF, Mawer EB, Suda T (eds) Vitamin D: Basic Research and its Clincial Applications. de Gruyter, New York, pp 727‑30
265. 1979 The mechanism of action of vitamin D in the intestine Am J Clin Nutr 32:2322‑38
266. 1979 Stimulation of chick gut al­kaline phosphatase activity by actinomycin D and 1,25‑dihydroxy­vitamin D3: evidence for independent mechanisms J Lab Clin Med 94:88‑94
267. 1979 Work induced muscle hypertrophy in vitamin D deficient rats. Am J Clin Nutr 32:515‑6.
268. 1979 Meaning of nonparallel 1,25(OH)2D medi­ated response relationships in intestine and bone to dose and time. Norman AW, Schaefer K, Herrath DV, Grigoleit HG, Coburn JW, DeLuca HF, Mawer EB, Suda T (eds) Vitamin D: Basic Research and its Clinical Applica­tions. de Gruyter, New York, pp 639‑42
269. 1978 Intestinal re­sponse to 1,25‑dihydroxycholecalciferol. I. RNA polymerase, alkaline phospha­tase, calcium and phosphorus uptake in vitro and in vivo calcium transport and accumulation Biochim Biophys Acta 538:23‑33.
270. 1978 A biochemical model for the ionic control of 25 hydroxy­vi­tamin D3 1 ‑hydroxylase. J Biol Chem 253:3042‑8
271. 1978 Independence of 1,25‑dihy­droxy­vitamin D3 mediated calcium transport from de novo RNA and protein synthe­sis J Biol Chem 253:484‑8
272. 1978 Ionic control of 1,25‑dihydroxyvitamin D3 production by isolated chick renal mitochondria: influence of anions and sucrose. Biochim Biophys Acta 538:127‑38
273. 1978 Immunoperoxidase localization of vitamin D dependent calcium binding protein. J Histochem Cytochem 25:628‑34
274. 1978 Intestinal re­sponse to 1,25‑dihydroxycholecalciferol. II. A timed study of the intracellu­­lar localization of calcium binding protein Biochim Biophys Acta 538:34‑41
275. 1977 The dissociation of 1,25(OH)2D3‑induced CaBP production and alkaline phosphatase activity from cal­cium transport by actinomycin Dcontinuedandcycloh­eximide Norman AW, Coburn JW, DeLuca HF, Fraser D, Grigoleit HG, Schaefer K (eds) Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism. de Gruyter, Elmsford, NY, pp 223‑5
276. 1977 The effect of 1,25‑DHCC on the calcium accumulation, calcium transport, and calcium binding protein in the presence and absence of cycloheximide. Norman AW, Coburn JW, DeLuca HF, Fraser D, Grigoleit HG, Schaefer K (eds) Vitamin D: Bio­chemical, Chemical and Clinical Aspects Related to Calcium Metabolism. de Gruyter, Elmsford, NY, pp 345‑7.
277. 1977 The effect of 1,25‑dihydroxyvitamin D3 on the distribution of alkaline phosphatase activity along the chick intestinal villus Biochim Biophys Acta 499:61‑6
278. 1977 1,25‑dihy­droxycholecalcif­erol stimulation of calcium binding protein specific m‑RNA Norman AW, Coburn JW, DeLuca HR, Fraser D, Grigoleit HG, Schaefer K (eds) Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metab­olism. de Gruyter, Elmsford, NY, pp 227‑9.
279. 1976 The ionic control of 1,25‑di­hydroxy­vita­min D3 synthesis in isolated chick renal mitochondria: the role of potassi­um Biochim Biophys Acta 437:394‑402
280. 1975 The ionic control of 1,25‑dihydroxyvitamin D3 pro­duc­tion in isolated chick renal tubules J Clin Invest 55:292-8
281. 1975 Calcium and nonvesicular secretion in the kidney: calcium and mitochondrial functions Carafoli E (ed) Calcium Transport in Contrac­tion and Secretion. North Holland Publishing Co, pp 111‑21
282. 1975 The ionic control of 1,25‑dihydroxyvitamin D3 pro­duc­tion in isolated chick renal mitochondria: the role of calcium as influenced by inorganic phosphate and hydrogen ion J Clin Invest 55:299‑304
283. 1974 The metabolism of 25‑hydroxycholecalciferol by iso­lated renal tubules in vitro as studied by a new chromatographic tech­nique Biochim Biophys Acta 362:425‑38
284. 1974 A comparison of the metabolism of 25‑hydroxy­vitamin D3 by chick renal tubules, homogenates, and mitochondria Biochim Biophys Acta 362:439‑47
285. 1972 Hormonal control of the renal conversion of 25‑hydroxycholecalciferol to 1,25‑dihydroxychole­cal­cifer­ol J Clin Invest 51:2502‑4.
286. 1966 Microtubules and the migration of pigment in the melanophores of Fundulus heteroclitus L. Protoplasma LXI:322‑5.


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.